全文获取类型
收费全文 | 79篇 |
免费 | 3篇 |
专业分类
儿科学 | 1篇 |
基础医学 | 12篇 |
口腔科学 | 1篇 |
临床医学 | 3篇 |
内科学 | 27篇 |
皮肤病学 | 3篇 |
神经病学 | 6篇 |
外科学 | 12篇 |
预防医学 | 3篇 |
药学 | 2篇 |
肿瘤学 | 12篇 |
出版年
2023年 | 1篇 |
2022年 | 1篇 |
2021年 | 2篇 |
2020年 | 1篇 |
2018年 | 2篇 |
2016年 | 1篇 |
2015年 | 1篇 |
2014年 | 6篇 |
2013年 | 1篇 |
2012年 | 8篇 |
2011年 | 9篇 |
2010年 | 3篇 |
2009年 | 1篇 |
2008年 | 4篇 |
2007年 | 1篇 |
2006年 | 2篇 |
2005年 | 5篇 |
2004年 | 5篇 |
2002年 | 6篇 |
2001年 | 3篇 |
2000年 | 3篇 |
1999年 | 2篇 |
1997年 | 1篇 |
1993年 | 1篇 |
1991年 | 1篇 |
1990年 | 4篇 |
1983年 | 2篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1967年 | 1篇 |
排序方式: 共有82条查询结果,搜索用时 15 毫秒
51.
Jono S McKee MD Murry CE Shioi A Nishizawa Y Mori K Morii H Giachelli CM 《Circulation research》2000,87(7):E10-E17
Vascular calcification is a common finding in atherosclerosis and a serious problem in diabetic and uremic patients. Because of the correlation of hyperphosphatemia and vascular calcification, the ability of extracellular inorganic phosphate levels to regulate human aortic smooth muscle cell (HSMC) culture mineralization in vitro was examined. HSMCs cultured in media containing normal physiological levels of inorganic phosphate (1.4 mmol/L) did not mineralize. In contrast, HSMCs cultured in media containing phosphate levels comparable to those seen in hyperphosphatemic individuals (>1.4 mmol/L) showed dose-dependent increases in mineral deposition. Mechanistic studies revealed that elevated phosphate treatment of HSMCs also enhanced the expression of the osteoblastic differentiation markers osteocalcin and Cbfa-1. The effects of elevated phosphate on HSMCs were mediated by a sodium-dependent phosphate cotransporter (NPC), as indicated by the ability of the specific NPC inhibitor phosphonoformic acid, to dose dependently inhibit phosphate-induced calcium deposition as well as osteocalcin and Cbfa-1 gene expression. With the use of polymerase chain reaction and Northern blot analyses, the NPC in HSMCs was identified as Pit-1 (Glvr-1), a member of the novel type III NPCs. These data suggest that elevated phosphate may directly stimulate HSMCs to undergo phenotypic changes that predispose to calcification and offer a novel explanation of the phenomenon of vascular calcification under hyperphosphatemic conditions. The full text of this article is available at http://www.circresaha.org. 相似文献
52.
Violence and psychiatric disorder in the community: evidence from the Epidemiologic Catchment Area surveys 总被引:15,自引:0,他引:15
Data from the Epidemiologic Catchment Area survey were used to examine the relationship between violence and psychiatric disorders among adults living in the community. Psychiatric assessment of survey respondents was based on the Diagnostic Interview Schedule, which also provided self-report information about violent behavior. Those who reported violent behavior within the preceding year tended to be young, male, and of low socioeconomic status, and more than half met DSM-III criteria for one or more psychiatric disorders. Subjects with alcohol or drug use disorders were more than twice as likely as those with schizophrenia to report violent behavior. In a multivariate model of the predictors of violence, a significant interaction effect was found between major mental illness and substance abuse. The risk of violent behavior increased with the number of psychiatric diagnoses for which respondents met DSM-III criteria. 相似文献
53.
Misumi Y Ueda M Obayashi K Jono H Su Y Yamashita T Ohshima T Ando Y Uchino M 《Human pathology》2012,43(1):96-104
Transthyretin-related familial amyloidotic polyneuropathy is a systemic amyloidosis caused by mutations in the transthyretin gene. Extracellular deposition of amyloid is the common pathologic hallmark of amyloidoses including Alzheimer disease, AL amyloidosis, AA amyloidosis, and familial amyloidotic polyneuropathy. However, the exact relationship between amyloid deposition and cell death has not yet been clarified. To elucidate this relationship, we studied the effect of transthyretin amyloid fibrils and prefibrillar aggregates on cells by using autopsy tissues obtained from 8 patients with familial amyloidotic polyneuropathy, as well as cultured cell lines. Ultrastructural studies of amyloid-laden cardiomyocytes showed that intracellular structural changes correlated with the degree of amyloid deposition and may reflect metabolic disturbances caused by physical limitations imposed by the amyloid deposits. Amyloid-laden vascular endothelial cells, mesangial cells, smooth muscle cells, Schwann cells, and cardiomyocytes, however, had well-preserved cell nuclei and showed no apoptotic changes, even when cells were completely surrounded by prefibrillar transthyretin aggregates and amyloid fibrils. Synthesized prefibrillar transthyretin aggregates, transthyretin fibrils, and amyloid fibrils obtained from patients with familial amyloidotic polyneuropathy evidenced no cytotoxicity in cell culture experiments. Our data thus indicate that neither transthyretin amyloid fibrils nor prefibrillar transthyretin aggregates directly induced apoptosis. However, cellular metabolic disturbances caused by cells' being physically confined by amyloid deposits may induce cell degeneration. 相似文献
54.
55.
Jono S Ikari Y Vermeer C Dissel P Hasegawa K Shioi A Taniwaki H Kizu A Nishizawa Y Saito S 《Thrombosis and haemostasis》2004,91(4):790-794
Matrix Gla protein (MGP) is an extracellular matrix protein with wide tissue distribution. It has been demonstrated that the expression of MGP is detected not only in the normal blood vessels but also calcified atherosclerotic plaques, and that MGP deficient mice develop extensive arterial calcification. MGP is thought to be a regulator of vascular calcification. A recent clinical study demonstrates the association between polymorphisms of the MGP gene and increased risk of myocardial infarction. However, there are no reports of the relationship between serum MGP levels and coronary artery calcification (CAC). We evaluated the severity of CAC using electron-beam computed tomography (EBCT), and measured serum MGP levels by enzyme-linked immunosorbent assay in 115 subjects with suspected coronary artery disease. CAC scores were correlated with traditional risk factors, such as age, gender, hyper-tension, diabetes, hyperlipidemia and smoking. The serum MGP levels were lower in patients with CAC than in those without CAC (p<0.001). As the severity of CAC increased, there was a significant decrease in serum MGP levels. Serum MGP levels (U/L) were 116.7 +/- 20.3, 104.9 +/- 19.2, 95.2 +/- 15.2 and 82.2 +/- 19.7, (medians 115.5, 105.0, 94.8, and 81.9) for the subjects with normal (CAC score=0), mild (CAC score=1 to 99), moderate (CAC score=100 to 400), and severe (CAC score >400) coronary calcification, respectively. We found that serum MGP levels are inversely correlated with the severity of CAC. These data suggest a possible role for MGP in the development of vascular calcification. 相似文献
56.
Jono S 《Clinical calcium》2001,11(4):429-435
Until recently, vascular calcification was considered to be a passive, degenerative, and end-stage process of vascular disease. However, the observation of bone matrix proteins in calcified vascular tissues has changed this paradigm. Vascular calcification is an actively regulated process in which vascular cells may acquire osteoblast-like function. An important regulator of vascular calcification is the levels of Inorganic Phosphate (Pi). Pi directly regulates calcification through a sodium-dependent phosphate transporter system. 相似文献
57.
Jono S 《Clinical calcium》2001,11(10):1340-1343
Soft tissue calcifications are frequent complication in patients with chronic renal failure. Numerous underlying factors are thought to favor their formation, in particular increased calcium X phosphate product and hyperparathyroidism. Since hyperphosphatemia and /or an increase of the CaXP product are most often involved, a strict control of plasma phosphorus and the avoidance of an increase of plasma calcium should be the goal to be attained permanently in all uremic patients. Various types of drugs have been considered for the treatment of severe soft tissue calcification in uremic patients, including phosphate binder, bisphosphonates and calcitonin. 相似文献
58.
Vascular calcification in chronic kidney disease 总被引:9,自引:0,他引:9
Vascular calcification is often encountered in advanced atherosclerotic lesions and is a common consequence of aging. Calcification
of the coronary arteries has been positively correlated with coronary atherosclerotic plaque burden, increased risk of myocardial
infarction, and plaque instability. Chronic kidney disease (CKD) patients have two to five times more coronary artery calcification
than healthy age-matched individuals. Vascular calcification is a strong prognostic marker of cardiovascular disease mortality
in CKD patients. Vascular calcification has long been considered to be a passive, degenerative, and end-stage process of atherosclerosis
and inflammation. However, recent evidence indicates that bone matrix proteins such as osteopontin, matrix Gla protein (MGP),
and osteocalcin are expressed in calcified atherosclerotic lesions, and that calcium-regulating hormones such as vitamin D3 and parathyroid hormone-related protein regulate vascular calcification in in vitro vascular calcification models based on
cultured aortic smooth muscle cells. These findings suggest that vascular calcification is an actively regulated process similar
to osteogenesis, and that bone-associated proteins may be involved in the development of vascular calcification. The pathogenesis
of vascular calcification in CKD is not well understood and is almost multifactorial. In CKD patients, several studies have
found associations of both traditional risk factors, such as hypertension, hyperlipidemia, and diabetes, and uremic-specific
risk factors with vascular calcification. Most patients with progressive CKD develop hyperphosphatemia. An elevated phosphate
level is an important risk factor for the development of calcification and cardiovascular mortality in CKD patients. Thus,
it is hypothesized that an important regulator of vascular calcification is the level of inorganic phosphate. In order to
test this hypothesis, we characterized the response of human smooth muscle cell (HSMC) cultures to inorganic phosphate levels.
Our findings indicate that inorganic phosphate directly regulates HSMC calcification through a sodium-dependent phosphate
transporter mechanism. After treatment with elevated phosphate, there is a loss of smooth muscle lineage markers, such as
α-actin and SM-22α, and a simultaneous gain of osteogenic markers such as cbfa-1 and osteocalcin. Elevated phosphate may directly
stimulate HSMC to undergo phenotypic changes that predispose to calcification, and offer a novel explanation of the phenomenon
of vascular calcification under hyperphosphatemic conditions. Furthermore, putative calcification inhibitory molecules have
been identified using mouse mutational analyses, including MGP, β-glucosidase, fetuin-A, and osteoprotegerin. Mutant mice
deficient in these molecules present with enhanced cardiovascular calcification, demonstrating that specific molecules are
normally important in suppressing vascular calcification. These findings suggest that the balance of inducers, such as phosphate,
and inhibitors, such as MGP, fetuin-A, and others, are likely to control whether or not calcification occurs under pathological
conditions. 相似文献
59.
60.
Matrix Gla protein (MGP) is an extracellular matrix protein and originally from bone tissue. MGP expression is demonstrated not only in calcified tissues but also in soft tissues. MGP is expressed in the human normal blood vessels as well as atherosclerotic plaques. High levels of MGP were found in human atheromatous plaques. There is no significant correlation between serum MGP levels and bone volume. In cardiovascular disease patients, serum MGP levels were significantly decreased. This finding suggests that serum MGP levels may reflect the progression of cardiovascular disease. 相似文献